Abstract: The invention provides compounds of formula I: wherein R1 to R4 and n have any of the meanings defined in the specification and their pharmaceutically acceptable salts. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I, and therapeutic methods for treating pain and treating other conditions which involve, for example, binding opioid receptors using compounds of formula I.

Abstract: Crystalline forms of the compounds (R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1-(pyrrolidinocarbonyl)-ethyl]-benzimidazole and the monohydrochloride thereof, processes for the preparation thereof and the use thereof as pharmaceutical compositions.

Abstract: The present invention relates to processes for preparing peptides and to intermediates involved in such processes, e.g. a process for preparing a compound of formula VIII wherein R12 and R13 are as defined herein.

Abstract: Compounds of formula (I): [where: R1 is a direct bond, oxygen, a group >CH2, sulphur, a group >C?O, a group-(CH2)2— or a group-N—Ra, where Ra is hydrogen or alkyl; R3, R4, R5 and R6 are hydrogen or substituents?; R8, R9, R10 and R11 are hydrogen, hydroxy or alkyl; or R9 and R11 are joined to form a fused ring system with the benzene rings to which they are attached; R7 is a direct bond, oxygen or a —CH2-group; p is 0 or 1 ; substituents? are: alkyl, alkoxy, alkenyl, halogen, nitrile, hydroxyl, aryl, aralkyl, aryloxy, aralkyloxy, arylalkenyl, cycloalkyl, carboxy, carboxyalkoxy, alkoxycarbonyl, aryloxycarbonyl, alkylcarbonyloxy, alkanesulphonyl, arenesulphonyl, alkanoyl or arylcarbonyl; n is 1 to 12; R12 is hydrogen, methyl or ethyl; A is a group —[O(CHR13CHR14)a]y—, —[O(CH2)bCO]y-, or —[O(CH2)bCO](y-1)-[O(CHR13CHR14)a]—, where: one of R13 and R14 is hydrogen and the other is hydrogen, methyl or ethyl; a is 1 to 2 ; b is 4 to 5 ; Q is a residue of a polyhydroxy compound having from 2 to 6 hydroxy groups;

Abstract: The invention teaches an improved process for the manufacture of useful fluoran dyes of the structure according to formula 1 comprising condensing in an alkanesulfonic acid or an arenesulfonic acid to acid according to formula 2 with an aminodiphenylamine of formula 3 wherein R, R1-R6 are as defined in the specification.

Abstract: A process for the preparation of a compound of formula (I) or a single enantiomer thereof, or a salt or a solvate thereof, wherein W is a chiral auxiliary or hydrogen and P1 and P2 are each independently selected from hydrogen or a protecting group, which comprises: a)treatment of a compound of formula (II), or a salt or a solvate thereof, wherein W is a chiral auxiliary and P1 and P2 are each independently chosen from a protecting group, with a compound of formula (III) to form a resulting product, b) treating the resulting product with a reducing agent to form the compound of formula (I), or a single enantiomer thereof, or a salt or a solvate thereof.

Abstract: Process for the preparation of alkylene oxide which process comprises contacting organic hydroperoxide and alkene with a heterogeneous epoxidation catalyst and withdrawing a product stream comprising alkylene oxide and an alcohol as reaction products, in which process fresh catalyst is contacted with feed having a higher molar ratio of alkene to organic hydroperoxide than the molar ratio of normal operation.

Abstract: The invention relates to a process for the preparation of an epoxidation catalyst which process involves (a) drying a silica gel carrier having a weight average particle size of from 0.1 mm to 2 mm at a temperature of from more than 200° C. to 300° C., and (b) contacting the carrier obtained in step (a) with a gas stream containing titanium halide to obtain an impregnated carrier, and the use of such catalyst in the preparation of alkylene oxide.

Abstract: Compounds having the active site of natural lipoxins, but a longer tissue half-life are disclosed. In particular, 15-epi-lipoxins and their use in ameliorating undesired cell proliferation, which characterizes diseases such as cancer, are also disclosed.

Abstract: A novel bis-chelating composition characterized by formula I: wherein M is a Group VB element; R1 and R2 are each independently selected from hydrogen and monovalent hydrocarbyl radicals; or R1 and R2 are bonded together to form a diradical; or one of R1 or R2 is hydrogen or a monovalent hydrocarbyl radical, while the other of R1 or R2 is a hydrocarbyl radical bonded to an atom in Ar; wherein Ar is selected from 1,2-arylenes; Q is selected from 1,2-arylenes, 2,2?-bisarylenes and alkyl diradicals; and W is selected from II, III, IV, or V: wherein M is as defined hereinbefore; each R is independently selected from hydrogen and monovalent hydrocarbyl radicals; X is selected from alkyl and aryl diradicals; Ar1 and Ar2 are each independently selected from 1,2-arylenes;Ar3 and Ar4 are each independently selected from monovalent aryl radicals; and n in formula IV is 0 or 1.

Abstract: Disclosed are colorant compounds of the formulae wherein R1, R2, R3, M, A, E, G, J, m, n, and p are as defined herein.

Abstract: The present invention provides novel perfluoropolyether silanes, compositions containing the novel perfluoropolyether silanes and method of treating substrates, in particular substrates having a hard surface such as ceramics or glass, to render them water, oil, stain, and/or dirt repellent.

Abstract: A silicon compound represented by Formula (1). In Formula (1), R1 is a group independently selected respectively from the group consisting of a hydrogen atom, alkyl, substituted or non-substituted aryl and substituted or non-substituted arylalkyl, and A1 is an organic group substituted with a halogenated sulfonyl group and is preferably a group represented by Formula (2). In Formula (2), X is halogen; R2 is alkyl; a is an integer of 0 to 2; and Z1 is a single bond or alkylene having a carbon number of 1 to 10. The silicon compound provided by the present invention is a silsesquioxane derivative having an excellent living polymerizable radical polymerization initiating function. For example, it is possible to commence polymerization by allowing an acryl base monomer to coexist to form an acryl base polymer making use of one point of the structure of the silsesquioxane in the present invention as a starting point.

Abstract: An improved process for the manufacture of formylphosphonic acid derivatives is reported. An aminomethylphosphonic acid substrate is contacted with a reagent selected from the group consisting of water, an alcohol, a phenol compound, and mixtures thereof and an oxidizing gas in the presence of a catalyst to form a reaction product mixture containing a formylphosphonic acid derivative and the conditions under which said contacting is carried out are controlled so that no more than 50% of the formylphosphonic acid derivative formed in the reaction product mixture is consumed by reaction with the reagent.

Abstract: This invention relates to a process for converting a hydrocarbon reactant to a product comprising an oxygenate or a nitrile, the process comprising: (A) flowing a reactant composition comprising the hydrocarbon reactant, and oxygen or a source of oxygen, and optionally ammonia, through a microchannel reactor in contact with a catalyst to convert the hydrocarbon reactant to the product, the hydrocarbon reactant undergoing an exothermic reaction in the microchannel reactor; (B) transferring heat from the microchannel reactor to a heat exchanger during step (A); and (C) quenching the product from step (A).

Abstract: Isolated cinacalcet carbamate, processes for the preparation thereof, and processes for the use of cinacalcet carbamate as a reference marker and standard are provided. Also provided are cinacalcet salts substantially free of cinacalcet carbamate, and processes for the preparation thereof.

Abstract: A method is described for the preparation of polymorphic forms of water-soluble derivatives of probucol compounds having the following formula where R1, R2, R3, R4, R5, R6, Z and Z? are defined herein.

Abstract: Provided are methods for manufacturing compounds of Formula I wherein all substituents are described herein.

Abstract: The present invention discloses novel steroid mimics wherein a tri- or tetravalent phosphorous atom is isosterically substituted at any one of the seventeen positions occupied by the carbon atom in the steroidal skeleton, and wherein each adjacent position to the phosphorous is either unsubstituted or optionally substituted by nitrogen or an oxygen atom to satisfy the valency of said phosphorous atom. The invention is illustrated schematically below using both aromatic and non-aromatic steroids. Although the isosteric substitution phosphorous atom in the above structures 3–7 is indicated at 13, 14, and 17 positions, it is to be noted that the phosphorous can be substituted at any one of the seventeen positions in non-aromatic or eleven positions in aromatic steroids. The phosphorous atom may be trivalent or tetravalent, and may be radioactive or non-radioactive. The adjacent atoms, X, Y, or Z may be carbon, oxygen, or nitrogen.

Abstract: This invention is directed to compounds of the following formula (I): wherein R is either: wherein R1 and R2 are as defined in the specification; the use of these compounds for treating inflammatory disorders; and pharmaceutical compositions comprising a therapeutically effective amount of the above-defined compounds.

Abstract: The invention claimed herein provides a process to oxidize N-(5-alkoxy-2-methyl-4-nitrophenyl)acetamides to N-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids using potassium permanganate in the presence of magnesium sulfate in aqueous sulfolane or aqueous pyridine.

Abstract: The present invention relates to a process for the production of acrylic acid (AA) comprising the steps wherein: a) a 1st gas mixture comprising propylene, oxygen, an inert gas and steam is subjected to a 1st catalytic oxidation reaction stage thereby converting the propylene in the presence of a catalyst mainly into acrolein being contained in a 2nd gas mixture from said 1st catalytic oxidation reaction, b) said 2nd gas mixture from the 1st catalytic oxidation reaction stage is subjected to a 2nd catalytic oxidation reaction stage thereby converting the acrolein in the presence of a catalyst mainly into AA, being contained in a product gas, c) said product gas is subjected to a quench tower, wherein said AA is recovered as an aqueous solution comprising said AA being contained in the process water, wherein a process vent gas is obtained at the top of said quench tower, wherein, said 1st gas mixture has a steam/propylene ratio of >0.

Abstract: Initiators for atom transfer radical polymerizations are described. The initiators have an azlactone or ring-opened azlactone moiety to provide telechelic (co)polymers.

Abstract: The present invention relates to a method for synthesis of an acrylamide derivative, starting with dissolving a salt of a nucleophilic amine in water to form an aqueous solution and desalting said solution with a base, comprising the following steps: a) addition of dissolved activated acrylic acid derivative to said solution; b) acidification of aqueous phase; and c) extraction of said aqueous phase.

Abstract: The present invention relates to an improved process for preparing enantiomerically pure 3-hydroxy-3-phenyl-propylamines on an industrial scale using asymmetrical hydrogenation as a key step and optionally a special sequence of subsequent steps, using a catalyst system consisting of rhodium and chiral 4-(dicyclohexylphosphino)-2-(diphenyl-phosphino-methyl)-N-methyl-aminocarbonyl-pyrrolidine.

Abstract: The present invention provides a novel eco-friendly multi-functional catalyst system useful to obtain C2(n+1) aldol-derivative from Cn-alkenes where n ranges from 2 to 10 in a single step under hydroformylation reaction conditions and adol formation conditions.

Abstract: Processes for reducing color in PO3G are provided. The processes include contacting PO3G with an adsorbent and then separating the PO3G from the adsorbent by, for example, filtration. The process provides PO3G having an APHA color preferably less than about 50. The processes are desirably used for polymers having a molecular weight of about 250 to about 5000.

Abstract: Process for the manufacture of 1,1-difluoroethane by liquid-phase fluorination of 1,2-dichloroethane using hydrofluoric acid in the presence of a Lewis acid as catalyst and of FeCl3 as cocatalyst. Process for the manufacture of 1,1-difluoroethylene employing it.

Abstract: The present invention provides compounds of Formula I: wherein: R1 is a label (e.g., a detectable groups; an anti-tumor agent)s; L is present or absent and when present is a linking group; and x represents an integer from 1 to 10; or a pharmaceutically acceptable salt thereof. The compounds are useful for, among other things, identifying cysteine sulfenic acids in proteins and monitoring oxidative damage in proteins and cells.

Abstract: A low-pressure olefins recovery process and plant are described. The feed gas 300 is compressed 302, 304 and distilled 310 at a primary distillation pressure. The overhead stream 312 is chilled 318 at a pressure less than 30 kg/cm2 (430 psia) to partially condense the overheads. The primary distillation tower 310 is refluxed with at least a portion of the condensate 320. The overhead vapor is further chilled 318 and partially condensed and the condensate 322 is fed to a demethanizer 324. The remaining vapor 326 is cooled in a cold section 328 and the resultant liquid is phase-separated 330 and expanded 331, 334 to provide refrigeration for the cold section. The expanded vapor 332 from the cold section is recycled to the process gas compressor. The bottoms streams 338, 342 from the primary distillation zone and the demethanizer are fractionated into respective streams consisting essentially of ethylene 356, ethane 358, propylene 364, propane 366, C4's 346, and C5+ 348.

Abstract: An absorptive wound covering protecting material and a method for preparing an absorptive wound covering protecting material are characterized by solidifying a sponge raw solution containing no reinforcement that is obtained by mixing viscose and crystalline mirabilite as main raw materials, or a sponge raw solution obtained by mixing viscose containing a reinforcement comprising natural fibers having a length of at least 5 mm to 40 mm, and crystalline mirabilite as main raw materials, by performing a heat treatment on the sponge raw solution, and then forming the solidified cellulose sponge in a thickness somewhat greater than a desired thickness, and then forming the cellulose sponge in a sheet form having a desired thickness by compressing the cellulose sponge, and, if required, carboxymethylating hydroxyl groups in a glucose unit constituting a cellulose sponge so that a degree of substitution of the hydroxyl groups is from 0.5 to less than 1.0, and then, forming an incision the cellulose sponge.

Abstract: A self-adherent window dressing includes a fabric layer bounded by an edge. The fabric layer has an adhesive side, an opposite non-adhesive side, and an opening therein to allow for viewing therethrough. A reinforcement member is adhered to at least a portion of the fabric layer. A transparent film layer closes the opening and has first and second opposing sides. The film layer first side is non-adhesive and is mounted on the fabric layer adhesive side to close the opening in the fabric layer. The film layer second side has a skin adhering adhesive portion and an adhesive-free portion. The adhesive-free portion is disposed inwardly of the opening. The film layer adhesive-free portion is adapted not to stick to a wound, connector, or catheter disposed between the film layer adhesive-free portion and skin.

Abstract: A window dressing with an integral anchor includes a fabric layer having juxtaposed insertion site viewing and anchor member portions. The fabric layer has an adhesive side and an opposite non-adhesive side. The insertion site viewing portion is defined by an opening in the fabric layer. A transparent film layer having an adhesive skin-adhering side and an opposite non-adhesive side is adhered to the fabric layer adhesive side and closes the opening in the fabric layer. The anchor member portion includes a reinforcing structure disposed on the fabric layer. The reinforcing structure has an adhesive side and an opposite non-adhesive side. The non-adhesive side is adhered to the fabric layer adhesive side. A first removable securement device may be removably connected to the anchor member portion opposite the insertion site viewing portion, and a second removable securement device may be removably connected to the first removable securement device.

Abstract: The specification provides methods of preparing high-affinity antibodies to a macrophage migration inhibitory factor (MIF) in animals in which the MIF gene has been homozygously knocked-out (MIF?/?). Also provided are methods of preparing hybridomas which produce the anti-MIF antibodies, methods of administering the antibodies to treat inflammatory or cancerous conditions and/or diseases modulated by MIF, as well as compositions comprising said high-affinity anti-MIF antibodies.

Abstract: Methods of generating modified embryos and mammals by introduction of donor cells into an early stage embryo are provided, such that the resulting embryo and animal generated therefrom has a significant or complete contribution to all tissues from the donor cells and is capable of transmitting the donor cell DNA.

Abstract: Disclosed is an in vivo method of incorporating exogenous genetic material into the genome of a vertebrate, which involves administering to a male vertebrate's testis a gene delivery mixture comprising a viral vector, such as a retroviral vector, to deliver a polynucleotide encoding a desired trait or product. Also disclosed is an in vitro method of incorporating exogenous genetic material into the genome of a vertebrate, in which germ cells are obtained from a donor male vertebrate and are genetically modified in vitro, before being transferred to a recipient male vertebrate. After the transfer, the male vertebrate bearing the genetically modified germ cells is bred with a female vertebrate such that a transgenic progeny is produced that carries the polynucleotide in its genome. Also disclosed are non-human transgenic vertebrates produced in accordance with the method, including transgenic progeny.

Abstract: Isolated nucleic acid fragments encoding galactinol synthase are disclosed. Recombinant DNA construct(s) for use in altering expression of endogenous genes encoding galactinol synthase are also disclosed.

Abstract: The invention describes new acquired resistance genes in plants. A method of using the genes to make transgenic plants that are resistant to disease is also provided.

Abstract: The subject invention pertains to materials and methods for producing plants that are resistant to infection by geminiviruses and other related viruses. Methods of the invention comprise transforming a plant with a polynucleotide wherein when the polynucleotide is expressed in the plant, the transformed plant exhibits resistance to plant viral infections. Exemplified herein is the use of a polynucleotide encoding a Rep protein derived from tomato mottle geminivirus. The methods of the invention can be used to provide resistance to viral infection in plants such as tomato and tobacco. The present invention also concerns transformed and transgenic plants in plant tissue that express a polynucleotide encoding a plant virus Rep protein, or a fragment or variant thereof.

Abstract: The preparation and use of nucleic acid fragments useful in altering the oil phenotype in plants are disclosed. Recombinant DNA construct incorporating such nucleic acid fragments and suitable regulatory sequences can be used to create transgenic plants having altered lipid profiles. Methods for altering the oil phenotype in plants using such nucleic acid fragments also are disclosed.

Abstract: The present invention relates to DNA molecules that encode transcription regulatory regions. Furthermore, this present invention relates to nucleotide sequences encoding transcription regulatory regions that promote early seed enhanced or seed coat enhanced transcription of contiguous nucleotide sequences.

Abstract: A method for producing a transgenic plant, which comprises: (A) introducing a vector into a plant cell, wherein the vector is a vector for gene introduction into a plant and comprises: a desired gene, and a selectable marker gene comprising a gene encoding an enzyme which synthesizes auxin from an auxin precursor; (B) culturing the plant cell into which the genes are introduced by the vector, in the presence of an auxin precursor and/or an analogue thereof to thereby prepare a redifferentiated tissue, and detecting and selecting the redifferentiated tissues; and (C) culturing the redifferentiated tissue selected in (B) to redifferentiate a plant individual, and a vector for gene introduction into a plant, which comprises: a desired gene, and a selectable marker gene comprising an indoleacetamide hydrolase, iaaH, gene and an isopentenyl transferase, ipt, gene and being free of an tryptophan monooxygenase, iaaM, gene.

Abstract: This invention relates to an isolated nucleic acid fragment encoding a UDP-galactose 4-epimerase. The invention also relates to the construction of a chimeric gene encoding all or a portion of the UDP-galactose 4-epimerase, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the UDP-galactose 4-epimerase in a transformed host cell.

Abstract: The instant invention relates to the soybean variety designated 0037393. Provided by the invention are the seeds, plants and derivatives of the soybean variety 0037393. Also provided by the invention are tissue cultures of the soybean variety 0037393 and the plants regenerated therefrom. Still further provided by the invention are methods for producing soybean plants by crossing the soybean variety 0037393 with itself or another soybean variety and plants produced by such methods.

Abstract: The instant invention relates to the soybean variety designated SD82997. Provided by the invention are the seeds, plants and derivatives of the soybean variety SD82997. Also provided by the invention are tissue cultures of the soybean variety SD82997 and the plants regenerated therefrom. Still further provided by the invention are methods for producing soybean plants by crossing the soybean variety SD82997 with itself or another soybean variety and plants produced by such methods.

Abstract: The instant invention relates to the soybean variety designated SE72581. Provided by the invention are the seeds, plants and derivatives of the soybean variety SE72581. Also provided by the invention are tissue cultures of the soybean variety SE72581 and the plants regenerated therefrom. Still further provided by the invention are methods for producing soybean plants by crossing the soybean variety SE72581 with itself or another soybean variety and plants produced by such methods.

Abstract: According to the invention, there is provided a novel soybean variety designated XB28F05. This invention thus relates to the seeds of soybean variety XB28F05, to the plants of soybean XB28F05 to plant parts of soybean variety XB28F05 and to methods for producing a soybean plant produced by crossing plants of the soybean variety XB28F05 with another soybean plant, using XB28F05 as either the male or the female parent.

Abstract: According to the invention, there is provided a novel soybean variety designated 91M70. This invention thus relates to the seeds of soybean variety 91M70, to the plants of soybean 91M70 to plant parts of soybean variety 91M70 and to methods for producing a soybean plant produced by crossing plants of the soybean variety 91M70 with another soybean plant, using 91M70 as either the male or the female parent.

Abstract: The invention relates to the soybean variety designated 0384279. Provided by the invention are the seeds, plants and derivatives of the soybean variety 0384279. Also provided by the invention are tissue cultures of the soybean variety 0384279 and the plants regenerated therefrom. Still further provided by the invention are methods for producing soybean plants by crossing the soybean variety 0384279 with itself or another soybean variety and plants produced by such methods.

Abstract: According to the invention, there is provided a novel soybean variety designated XB18C06. This invention thus relates to the seeds of soybean variety XB18C06, to the plants of soybean XB18C06 to plant parts of soybean variety XB18C06 and to methods for producing a soybean plant produced by crossing plants of the soybean variety XB18C06 with another soybean plant, using XB18C06 as either the male or the female parent.